Group versus Individual Care in Patients with Long-Standing Type 1 and Type 2 Diabetes: A One-Year Prospective Noninferiority Study in a Tertiary Diabetes Clinic

Journal of Diabetes Research
Joelle SingerIlan Shimon

Abstract

To explore the feasibility and noninferiority of group care in a diabetes outpatient clinic in comparison with individual care. In this prospective, randomized, nonblinded, one center (university hospital) trial, 60 patients (28 with type 1 and 32 with type 2 diabetes) with a mean duration of diabetes of 22.5 ± 11.7 years were randomly assigned to group (6 patients per group) or individual care for one year. The primary endpoints were the change in HbA1c and visits to outpatient clinics. The secondary endpoints were changes in body mass index, blood pressure levels, waist circumference, non-HDL cholesterol, diabetes-related and well-being index questionnaires, and the number of hospitalizations. Group care was not inferior to individual care for any of the above parameters except for the number of visits to a primary care physician. Group care is feasible in a diabetes clinic and is as effective as individual care. Implementation of group care may facilitate access to specialized care to a larger population of patients with diabetes type 1 and 2.

References

Jul 12, 2003·The Diabetes Educator·Martha M Funnell, Robert M Anderson
Mar 23, 2005·The Diabetes Educator·Martha M FunnellTricia S Tang
Apr 23, 2005·The Cochrane Database of Systematic Reviews·T DeakinR D R R Williams
Aug 2, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M TrentoM Porta
May 26, 2006·Journal of Behavioral Medicine·Lori J Lange, John D Piette
Aug 18, 2009·Patient Education and Counseling·Robert M Anderson, Martha M Funnell
Mar 16, 2011·Archives of Internal Medicine·Aanand D NaikPaul Haidet
Mar 27, 2012·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Jeffrey A ReitzBrooke Salzman
Oct 18, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·T R S HajosF J Snoek
May 29, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·A NicolucciUNKNOWN DAWN2 Study Group
Aug 14, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Laura HousdenMartin Dawes

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03353376

Software Mentioned

ROMEO
SPSS Statistics

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.